文献速递心境障碍

锂盐床旁监测的可接受性与准确性评估

Acceptability and accuracy of point-of-care monitoring of lithium levels.
PubMed 文献 · Br J Psychiatry · 2026-06-26

该研究结合患者与临床医生问卷调查及对新型床旁检测设备Medimate Multireader的分析验证,评估锂盐监测床旁检测的可接受性与分析性能。多数患者和临床医生更倾向床旁检测而非传统静脉采血,设备与参考实验室方法相关性达0.96,偏差和一致性限均在预设±0.2 mmol/L性能规格内。

要点

  • 多数患者和临床医生偏好锂盐床旁检测而非传统静脉采血。
  • 静脉监测不便且具破坏性,家庭床旁检测可提高患者服用锂盐意愿。
  • Medimate Multireader与参考方法相关系数0.96,分析一致性优秀。

核心结论

  • 锂盐床旁检测是静脉血监测可行且分析稳健的替代方案。
  • 床旁检测可减轻定期静脉采血的后勤负担,该负担是锂盐使用的主要障碍。

研究设计与样本

  • 研究结合患者与临床医生对锂盐治疗和监测态度的问卷调查,以及对新型床旁检测设备Medimate Multireader的分析评估。
  • 分析验证评估了设备与参考实验室方法相比的准确性、偏差、一致性和可重复性。

主要发现

  • 多数患者和临床医生偏好床旁检测而非传统静脉采血。
  • 许多患者认为静脉监测不便且具破坏性,并表示若有家庭床旁检测会更愿意服用锂盐。
  • 临床医生认为静脉采血的频率和后勤需求是开具锂盐的主要障碍。
  • Medimate Multireader与参考方法相关系数为0.96,平均偏差和一致性限均在预设±0.2 mmol/L性能规格内。
  • 调查受访者对设备用于患者自操作家庭检测的前景持积极看法。

关键数值与推荐

  • Medimate Multireader与参考方法相关系数为0.96。
  • 平均偏差和一致性限均在预设±0.2 mmol/L性能规格内。

临床怎么用

  • 床旁检测可减少定期静脉采血的后勤负担,可能支持改善锂盐可及性、安全性和依从性。
  • 床旁检测符合英国国家医疗服务体系优先发展数字化社区护理的方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lithium is the gold-standard treatment for bipolar disorder, yet its use is often restricted by the logistical burden of regular venous blood sampling and laboratory monitoring. Point-of-care testing (POCT) offers a potential alternative, but evidence regarding acceptability and analytical performance is limited. AIMS: To evaluate patient and clinician attitudes towards POCT for lithium monitoring and analytically validate a novel POCT device (Medimate Multireader) against a reference laboratory method. METHOD: We combined patient and clinician surveys on attitudes towards lithium treatment and monitoring with an analytical evaluation of the Medimate Multireader, a novel POCT device. Survey data explored perceived barriers to lithium use and preferences for monitoring methods. Analytical validation assessed accuracy, bias, agreement and reproducibility compared with a reference laboratory method. RESULTS: Most patients and clinicians preferred POCT to conventional venous sampling. Many patients described venous monitoring as inconvenient and disruptive and indicated that they would be more willing to take lithium if home-based POCT were available. Clinicians identified the frequency and logistical demands of venous blood testing as the principal barrier to prescribing lithium. The Medimate Multireader demonstrated excellent analytical agreement with the reference method, with a correlation coefficient of 0.96 and mean bias and limits of agreement within the predefined ±0.2 mmol/L performance specification. The potential of the device for patient-operated home-based testing was viewed favourably by survey respondents. CONCLUSIONS: POCT for lithium provides a feasible and analytically robust alternative to venous blood monitoring. By reducing the logistical burden of regular venous sampling, a key barrier to lithium use, POCT aligns with National Health Service priorities for digitally enabled community-based care and may support improved access, safety and adherence.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Atkins M, Lagman C, Oloyede E, et al. Acceptability and accuracy of point-of-care monitoring of lithium levels. Br J Psychiatry. 2026. PMID: 42357937. doi:10.1192/bjp.2026.10695

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。